On February 11, 2009, Mead Johnson Nutrition Company, a division of Bristol-Myers Squibb, priced an initial offering of $720 million of its Class A common stock for sale to the public. The offering, which was increased from 25 million shares to 30 million shares, was priced at $24 per share. The underwriters have a 30-day option to purchase up to an additional 4.5 million shares to cover over-allotments, if any. This is the first U.S. initial public offering of 2009.
The lawyers involved in this transaction include partners Ronald Cami and Susan Webster and associates Matthias G. Baudisch, Michael Kim, Justin S. Tichauer and David W. Azarkh on corporate matters and partners Stephen L. Gordon and Lauren Angelilli and associate Luke A. Facer on tax matters.